Lmf Acquisition Opportunities Stock Today
| ICU Stock | USD 2.13 0.08 3.90% |
Performance0 of 100
| Odds Of DistressOver 81
|
LMF Acquisition is selling for under 2.13 as of the 26th of November 2024; that is 3.90 percent increase since the beginning of the trading day. The stock's last reported lowest price was 2.05. LMF Acquisition has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. Equity ratings for LMF Acquisition Opportunities are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 28th of August 2024 and ending today, the 26th of November 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 28th of October 2022 | Category Healthcare | Classification Health Care |
SeaStar Medical Holding Corporation, a medical device company, focuses on providing novel solutions and services to treat hyperinflammation and cytokine storm in critically ill patients. It is developing products in various therapeutic areas, including pediatric and adult acute kidney injury on CRRT cardiorenal syndrome in congestive heart failure with and without LVAD myocardial stunning in end stage renal disease and hepatorenal syndrome. The company has 4.46 M outstanding shares of which 288.07 K shares are currently shorted by investors with about 4.33 days to cover. More on LMF Acquisition Opportunities
Moving together with LMF Stock
| 0.81 | ME | 23Andme Holding | PairCorr |
| 0.88 | VALN | Valneva SE ADR | PairCorr |
| 0.84 | JNJ | Johnson Johnson Fiscal Year End 28th of January 2025 | PairCorr |
Moving against LMF Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
LMF Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| President CEO | Eric Schlorff | |||||||||||||||||||||||||||||||||||||||||||||
| Thematic Idea | Medical Equipment (View all Themes) | |||||||||||||||||||||||||||||||||||||||||||||
| Old Names | [ICT AUTOMATISERING, ICT GROUP (ICU.SG)] | |||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite, SPASX All Technology, NASDAQ Health Care, Medical Equipment, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||
LMF Acquisition can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand LMF Acquisition's financial leverage. It provides some insight into what part of LMF Acquisition's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||
LMF Acquisition Opportunities (ICU) is traded on NASDAQ Exchange in USA. It is located in 3513 Brighton Boulevard, Denver, CO, United States, 80216 and employs 12 people. LMF Acquisition is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Nano-Cap' category with a total capitalization of 9.15 M. LMF Acquisition Oppo runs under Biotechnology sector within Health Care industry. The entity has 4.46 M outstanding shares of which 288.07 K shares are currently shorted by investors with about 4.33 days to cover.
LMF Acquisition Opportunities has about 49 K in cash with (10.29 M) of positive cash flow from operations.
Check LMF Acquisition Probability Of Bankruptcy
Ownership AllocationLMF Acquisition Opportunities secures 8.45 % of its outstanding shares held by insiders and 4.93 % owned by institutional investors.
Check LMF Ownership Details
LMF Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Goss Wealth Management Llc | 2024-06-30 | 272 | |
| Tsfg, Llc | 2024-09-30 | 140 | |
| Game Plan Financial Advisors, Llc | 2024-06-30 | 100.0 | |
| Jpmorgan Chase & Co | 2024-06-30 | 6.0 | |
| Qube Research & Technologies | 2024-06-30 | 1.0 | |
| Goldman Sachs Group Inc | 2024-06-30 | 0.0 | |
| State Street Corp | 2024-06-30 | 0.0 | |
| Sfmg Llc | 2024-06-30 | 0.0 | |
| Wells Fargo & Co | 2024-06-30 | 0.0 | |
| Vanguard Group Inc | 2024-09-30 | 70.3 K | |
| Geode Capital Management, Llc | 2024-09-30 | 39.8 K |
LMF Acquisition Historical Income Statement
LMF Stock Against Markets
LMF Acquisition Corporate Management
| Sai Iyer | Senior Research | Profile | |
| M FACP | Chief Officer | Profile | |
| Tim Varacek | Senior Operations | Profile | |
| Tom Mullen | Vice Development | Profile | |
| Caryl Baron | Interim Officer | Profile | |
| David MD | CoFounder Director | Profile |
Additional Tools for LMF Stock Analysis
When running LMF Acquisition's price analysis, check to measure LMF Acquisition's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy LMF Acquisition is operating at the current time. Most of LMF Acquisition's value examination focuses on studying past and present price action to predict the probability of LMF Acquisition's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move LMF Acquisition's price. Additionally, you may evaluate how the addition of LMF Acquisition to your portfolios can decrease your overall portfolio volatility.